Literature DB >> 9215151

The hormonal receptor status of uterine carcinosarcomas (mixed müllerian tumours): an immunohistochemical study.

A C Ansink1, P A Cross, P Scorer, A de Barros Lopes, J M Monaghan.   

Abstract

AIM: To investigate the role of oestrogen and progesterone receptor status in uterine carcinosarcomas (mixed Müllerian tumours) to see whether the receptors were identifiable, and if so whether they were of significance clinically.
METHODS: 11 cases of uterine carcinosarcoma were identified from clinical and pathology records. An immunohistochemical method was used to demonstrate oestrogen and progesterone hormone receptors on paraffin embedded material, with suitable tissue controls, staining being recorded.
RESULTS: 10 of 11 cases showed staining for one or both hormone receptors in normal tissue adjacent to tumour. In four carcinosarcoma cases, staining for one or both receptors was shown within the epithelial component (appearing to correlate with the degree of epithelial differentiation); two of these cases had staining within sarcomatous areas. Two of the three patients still alive had epithelial hormone receptor positivity.
CONCLUSIONS: Receptors for oestrogen and progesterone were found in four of 11 cases of uterine carcinosarcoma, using paraffin embedded material. There may be an association between hormone receptor positivity and clinical outcome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9215151      PMCID: PMC499885          DOI: 10.1136/jcp.50.4.328

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  20 in total

1.  Low-grade stromal sarcoma: DNA flow cytometric analysis and estrogen progesterone receptor data.

Authors:  C J Dunton; M L Kelsten; S E Brooks; M J Viglione; J A Carlson; J J Mikuta
Journal:  Gynecol Oncol       Date:  1990-05       Impact factor: 5.482

2.  Estrogen receptor content, immunohistochemically determined by monoclonal antibodies, in endometrial stromal sarcoma.

Authors:  P Tosi; V Sforza; R Santopietro
Journal:  Obstet Gynecol       Date:  1989-01       Impact factor: 7.661

3.  Endometrial stromal sarcoma expression of estrogen receptors, progesterone receptors and estrogen-induced srp27 (24K) suggests hormone responsiveness.

Authors:  D Navarro; J J Cabrera; L León; R Chirino; L Fernández; A López; J F Rivero; P Fernández; O Falcón; P Jiménez
Journal:  J Steroid Biochem Mol Biol       Date:  1992-03       Impact factor: 4.292

4.  Uterine sarcoma: steroid receptors and response to hormonal therapy.

Authors:  K Wade; M A Quinn; I Hammond; K Williams; M Cauchi
Journal:  Gynecol Oncol       Date:  1990-12       Impact factor: 5.482

5.  Endometrial stromal sarcoma: a clinicopathologic study of 11 cases with determination of estrogen and progestin receptor levels in three tumors.

Authors:  L Katz; M J Merino; H Sakamoto; P E Schwartz
Journal:  Gynecol Oncol       Date:  1987-01       Impact factor: 5.482

6.  Progesterone receptor levels independently predict survival in endometrial adenocarcinoma.

Authors:  H C Nyholm; I J Christensen; A L Nielsen
Journal:  Gynecol Oncol       Date:  1995-12       Impact factor: 5.482

7.  Sarcomas of the uterus: a clinicopathologic study of 119 patients.

Authors:  K V Kahanpää; T Wahlström; P Gröhn; E Heinonen; U Nieminen; O Widholm
Journal:  Obstet Gynecol       Date:  1986-03       Impact factor: 7.661

8.  Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study.

Authors:  F J Major; J A Blessing; S G Silverberg; C P Morrow; W T Creasman; J L Currie; E Yordan; M F Brady
Journal:  Cancer       Date:  1993-02-15       Impact factor: 6.860

9.  Malignant mixed müllerian tumor versus high-grade endometrial carcinoma and aggressive variants of endometrial carcinoma: a comparative analysis of survival.

Authors:  E George; T J Lillemoe; L B Twiggs; T Perrone
Journal:  Int J Gynecol Pathol       Date:  1995-01       Impact factor: 2.762

10.  Immunocytochemical analysis of uterine papillary serous carcinomas for estrogen and progesterone receptors.

Authors:  S A Umpierre; T W Burke; C Tornos; N Ordonez; C Levenback; M Morris
Journal:  Int J Gynecol Pathol       Date:  1994-04       Impact factor: 2.762

View more
  5 in total

Review 1.  Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?

Authors:  W G McCluggage
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

2.  Immunohistochemical studies on uterine carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma: expression and prognostic importance of ten different markers.

Authors:  Riitta Koivisto-Korander; Ralf Butzow; Anna-Maija Koivisto; Arto Leminen
Journal:  Tumour Biol       Date:  2010-12-16

3.  18F-fluorodeoxyglucose positron emission tomography in uterine carcinosarcoma.

Authors:  Kung-Chu Ho; Chyong-Huey Lai; Tzu-I Wu; Koon-Kwan Ng; Tzu-Chen Yen; Gigin Lin; Ting-Chang Chang; Chun-Chieh Wang; Swei Hsueh; Huei-Jean Huang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-19       Impact factor: 9.236

4.  Genetic characterisation of adult primary pleomorphic uterine rhabdomyosarcoma and comparison with uterine carcinosarcoma.

Authors:  Charles W Ashley; Arnaud Da Cruz Paula; Lorenzo Ferrando; Rodrigo Gularte-Mérida; Ana P M Sebastiao; David N Brown; Andrea M Gazzo; Fresia Pareja; Anthe Stylianou; Nadeem R Abu-Rustum; Jorge S Reis-Filho; Darya Buehler; Paul Weisman; Sarah Chiang; Britta Weigelt
Journal:  Histopathology       Date:  2021-04-19       Impact factor: 7.778

5.  Ovarian Carcinosarcoma with Retroperitoneal Para-Aortic Lymph Node Dissemination Followed by an Unusual Postoperative Complication: A Case Report with a Brief Literature Review.

Authors:  Stoyan Kostov; Yavor Kornovski; Yonka Ivanova; Deyan Dzhenkov; George Stoyanov; Stanislav Stoilov; Stanislav Slavchev; Ekaterina Trendafilova; Angel Yordanov
Journal:  Diagnostics (Basel)       Date:  2020-12-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.